Results 1 to 10 of about 502,506 (259)

AAV2/8 Anti-angiogenic Gene Therapy Using Single-Chain Antibodies Inhibits Murine Choroidal Neovascularization [PDF]

open access: yesMolecular Therapy: Methods & Clinical Development, 2019
While anti-angiogenic therapies for wet age-related macular degeneration (AMD) are effective for many patients, they require multiple injections and are expensive and prone to complications.
Chris P. Hughes   +8 more
doaj   +4 more sources

Advancement in the development of single chain antibodies using phage display technology [PDF]

open access: yesPeerJ
Phage display technology has become an important research tool in biological research, fundamentally changing the traditional monoclonal antibody preparation process, and has been widely used in the establishment of antigen-antibody libraries, drug ...
Xiaohui Zheng   +6 more
doaj   +3 more sources

Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2020
Hemostasis is a complex process involving the concerted action of molecular and vascular components. Its basic understanding as well as diagnostic and therapeutic aspects have greatly benefited from the use of monoclonal antibodies.
Ivan Peyron   +8 more
doaj   +2 more sources

Human single chain Fv antibodies and a complementarity determining region-derived peptide binding to amyloid-beta 1–42

open access: yesNeurobiology of Disease, 2004
A library of phage-displayed human single-chain Fv (scFv) antibodies was selected against the human amyloid-beta peptide (Aβ42). Two new anti-Aβ42 phage-displayed scFvs antibodies were obtained, and the sequences of their VH and Vκ genes were analyzed. A
K. Manoutcharian   +10 more
doaj   +3 more sources

A VHH-Based Anti-MUC1 Chimeric Antigen Receptor For Specific Retargeting Of Human Primary T Cells To MUC1-Positive Cancer Cells [PDF]

open access: yesCell Journal, 2021
Objective: Immunotherapy with redirected T cells that express a chimeric antigen receptor (CAR) is a promising prospect in cancer treatment. Most CARs use murine-derived single-chain variable fragments (scFvs) as an antigen targeting moiety, which may ...
Alireza Rajabzadeh   +4 more
doaj   +1 more source

Delicate balance among thermal stability, binding affinity, and conformational space explored by single-domain VHH antibodies

open access: yesScientific Reports, 2021
The high binding affinities and specificities of antibodies have led to their use as drugs and biosensors. Single-domain VHH antibodies exhibit high specificity and affinity but have higher stability and solubility than conventional antibodies as they ...
Emina Ikeuchi   +4 more
doaj   +1 more source

Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of ‘Almost Natural’ Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection

open access: yesFrontiers in Immunology, 2022
A subset of antibodies found in cattle comprises ultralong CDR-H3 regions of up to 70 amino acids. Interestingly, this type of immunoglobulin usually pairs with the single germline VL gene, V30 that is typically very conserved in sequence.
Daniel Klewinghaus   +6 more
doaj   +1 more source

Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1

open access: yesAntibodies, 2022
Monoclonal antibodies have been used successfully as recombinant protein therapy; however, for HIV, multiple broadly neutralizing antibodies may be necessary.
Elisabeth Narayanan   +7 more
doaj   +1 more source

Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2

open access: yesViruses, 2021
Nanobodies are 130 amino acid single-domain antibodies (VHH) derived from the unique heavy-chain-only subclass of Camelid immunogloblins. Their small molecular size, facile expression, high affinity and stability have combined to make them unique ...
Qilong Tang   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy